Newsroom | 62812 results

SHANGHAI--(BUSINESS WIRE)--Dans un contexte international complexe et face à des défis croissants, la China International Import Expo (CIIE) continue de jouer un rôle de plateforme incontournable pour les échanges commerciaux mondiaux. À seulement 100 jours de l'événement, la 8e édition de la CIIE se tiendra à Shanghai du 5 au 10 novembre. À ce jour, plus de 50 pays et organisations internationales ont confirmé leur participation au Pavillon national. La Suède et les Émirats arabes unis seront...

SHANGHAI--(BUSINESS WIRE)--Facing the complex international landscape and mounting challenges, China International Import Expo (CIIE) consistently acts as a platform for global business exchange. With only 100 days to go, the 8th CIIE is set to take place in Shanghai from November 5 to 10. As of now, over 50 countries and international organizations have confirmed their participation in the Country Pavilion. Sweden and the United Arab Emirates will serve as guest countries of honor at the 8th C...

GLASSBORO, N.J.--(BUSINESS WIRE)--Two transformative healthcare announcements mark a new era for New Jersey’s innovation economy—with GSVP emerging as a key catalyst behind both....

MELBOURNE, Fla.--(BUSINESS WIRE)--Sun Nuclear, a Mirion Medical company, will present significant additions to its comprehensive portfolio of Radiation Therapy Quality Management solutions at the 2025 American Association of Physicists in Medicine (AAPM) Annual Meeting, taking place July 27-29, in Washington, D.C. Attendees are invited to explore new software and hardware innovations designed to help elevate treatment quality, streamline workflows, and support safer care. Premiering at AAPM 202...

QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH) (the “Company” or “Delcath”), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announces that the Company granted equity awards, previously approved by the Company’s Compensation Committee, as material inducements to three individuals whose employment commenced in June 2025. The grants resulted in the right to purchase 52,500 shares of the Company’s common stock and...

HUNT VALLEY, Md.--(BUSINESS WIRE)--Omega Healthcare Investors, Inc. (NYSE:OHI) today announced that the Company’s Board of Directors declared a cash dividend of $0.67 per share on its common stock. The dividend is payable Friday, August 15, 2025, to common stockholders of record as of the close of business on Monday, August 4, 2025. Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfoli...

WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer Provides Regulatory Update on Elinzanetant for the Treatment of Moderate to Severe Hot Flashes Due to Menopause...

DUBLIN--(BUSINESS WIRE)--The "Adult-onset Still Disease Market: Focus on Regional and Country Analysis - Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering. Adult-onset still disease is a rare, systemic inflammatory disorder characterized by high spiking fevers, salmon-colored rashes, and arthritis. It primarily affects adults and is associated with an overactive immune response. Adult-onset still disease can lead to joint destruction, organ damage, and...

DUBLIN--(BUSINESS WIRE)--The "Pertussis Market - A Global and Regional Analysis: Focus on Regional and Country Analysis - Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering. The global pertussis market includes various vaccine formulations such as whole-cell vaccines and acellular vaccines, which are used in pediatric and adult immunization schedules. These vaccines are being continually improved for safety, efficacy, and patient acceptance. Acellular v...

DUBLIN--(BUSINESS WIRE)--The "Fabry Disease Market (By Treatment, Route of Administration, Product, End-User, Country Analysis), Key Company Profiles, Product Portfolio, Pipeline Product Analysis, Recent Developments and Market Dynamics - Global Forecast (2025 - 2030)" report has been added to ResearchAndMarkets.com's offering. The global Fabry disease treatment market was valued at US$ 2.22 Billion in 2024, and is predicted to reach US$ 3.86 Billion by 2030. The primary goal of Fabry disease t...